UNSPSC 85881705: Nonimaging nuclear medicine assay of blood using indium 111 (in-111)

This classification denotes the group of activities that yields an intervention or procedure of nonimaging nuclear medicine assay of blood using indium 111 (in-111). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code C763DZZ

UNSPSC 85881705 Nonimaging nuclear medicine assay of blood using indium 111 (In-111), a Commodity code, shows no relevant recent state and local procurement activity. The three most recent opportunities posted under this code in 2026 involve diagnostic imaging PACS implementation (San Mateo Medical Center), special education contracted services (Birdville Independent School District), and temporary health professional staffing across multiple clinical categories (Santa Clara County Health System) — none of which relate to nuclear medicine assay procedures or in-111 blood testing.

State and local procurement offices appear to misclassify opportunities under this code. No current solicitations align with the nominal scope of nonimaging nuclear medicine assays using indium-111 tracers. Practitioners should monitor whether this code remains dormant or receives corrections in future posting cycles, or consider whether nuclear medicine services in their target jurisdictions are procured under different UNSPSC families focused on clinical laboratory services or diagnostic imaging more broadly.